Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a digital hub keep mentally ill patients healthy at home?

NCT ID NCT05160701

Disease control Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a telehealth system called Medherent for people with serious mental illness living in the community. The system dispenses medication, monitors health data like blood pressure and blood sugar, and allows virtual doctor visits. Researchers will track whether this approach reduces hospital visits and improves health outcomes in 300 participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Medherent telehealth platform with Bluetooth devices and virtual visits
What this could lead to
If successful, this could offer a practical way to improve medication adherence and health outcomes for people with serious mental illness living in the community.
What could go wrong
This is an early-stage study with 300 participants, and results may not apply broadly. The intervention relies on technology access and user engagement, which could limit effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2022

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 88 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Serious Mental Illness Diagnosis * Prescribed psychiatric medications * 18 to 80 years old * Receives services by a participating community mental health agency at time of enrollment * Be unable to consent to the study as assessed by the consent questionnaire. * Sample 1: Current Users of Medherent or * Sample 2: Willing or able to authorize to have the Medherent device in your residence Exclusion Criteria: • Unable to have the Medherent device in residence

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mental disorders, severe are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

mental disorder psychiatric disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mental disorders, severe

Contacts and locations

Locations

  • University of Maryland

    Baltimore, Maryland, 20201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.